This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA approves inhaled insulin Exubera for diabetics
The FDA approved Pfizer Exubera the first inhaled insulin for adults, marking a new delivery method alongside injections. Analysts foresee potential $1 billion yearly sales. long term lung effects to be studied. use cautions include coughing and testing blood sugar remains necessary.
MENTIONED IN THIS ARTICLE
FDA
Washington, D.C
Food and Drug Administration
Pfizer Inc
Pfizer
Sanofi-Aventis
Nektar Therapeutics
American Diabetes Association
U.S
Steven Galson
Center For Drug Evaluation and Research
Linical
Nathaniel Clark
Clark
Robert Meyer
Will Cefalu
Eli Lilly and Co
Alkermes Inc
Robert Goldstein
Juvenile Diabetes Research Foundation International